Answer
Breastfeeding should be discontinued throughout treatment with polatuzumab vedotin (Polivy) and for at least 3 months after the last dose.
Sources for this answer
- Polivy 30 mg and 140 mg powder for concentrate for solution for infusionRoche Products Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 8Document updated
Sources checked